Source: Annual Congress 2005 - Gene expression, receptors and markers in lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Blouquit, A. Régnier, L. Dannhoffer, U. Zimmermann, B. Franc, T. Chinet (Boulogne, France). Expression of endothelin receptor subtypes in different pulmonary tumours. Eur Respir J 2005; 26: Suppl. 49, 2917

Member's Comments

No comment yet.

Related content which might interest you: Localization of endothelin receptor subtypes in human bronchiolar epithelium Source: Eur Respir J 2001; 18: Suppl. 33, 77s Year: 2001 Muscarinic receptors mediate up-regulation of endothelin-1 expression in human lung fibroblasts Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Selective versus non-selective endothelin receptor antagonists Source: Annual Congress 2005 - New treatments in pulmonary hypertension Year: 2005 Dual endothelin receptor antagonism: setting standards in PAH Source: Eur Respir Rev 2008; 17: 13-18 Year: 2007 Expression and functional involvement of muscarinic receptor 3 (M3) in human lung fibroblasts in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 121s Year: 2005 Endothelin receptor antagonists in pulmonary arterial hypertension Source: Eur Respir J 2008; 31: 407-415 Year: 2008 Dual endothelin receptor blockade: advances in pulmonary disease Source: Annual Congress 2008 - Mastering pulmonary arterial hypertension: defined by evidence - enhanced by experience Year: 2008 Estrogen receptor alpha gene polymorphisms and primary pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 352s Year: 2005 Effects of AT1 receptor blockade on pulmonary and systemic manifestations in a COPD/emphysema mouse model Source: Annual Congress 2009 - Preclinical models in drug development Year: 2009 Vasopressin is involved in endothelin receptor antagonist-induced fluid retention in rat. Differential effect of selective ETA and dual ETA/ETB receptor antagonists Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Monitoring of liver function in patients with pulmonary hypertension treated with endothelin receptor antagonists: The value of a novel monitoring system Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 Single centre experience with endothelin receptor blockade in pulmonary hypertension Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004 Endothelin-a receptor antagonists reduce eNOS gene expression in rats with chronic hypoxic pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 271s Year: 2003 Endothelin receptor expression in idiopathic pulmonary arterial hypertension: effect of bosentan and epoprostenol treatment Source: Eur Respir J 2011; 38: 851-860 Year: 2011 Imbalanced expression of the type I TGF-beta receptors ALK-1 in pulmonary fibrosis Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis Year: 2009 Expression of adenosine receptors in the peripheral lung from COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 13s Year: 2005 Enhanced expression of nicotinic alpha-1 acetylcholine receptor in lung cancer Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 Different expression pattern of endothelin receptors in primary human lung fibroblasts derived from idiopathic pulmonary fibrosis compared to healthy controls Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011 Endothelin and endothelin receptor A in lymphangioleiomyomatosis Source: Annual Congress 2007 - Biomarkers in inflammatory lung disease Year: 2007 Localization and expression of receptors for BNP (NPR-B) in human isolated bronchi Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009